Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,718
Total Claims
$1.6M
Drug Cost
864
Beneficiaries
$1,825
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+154%
Cost per patient vs peers
$1,825 vs $719 avg
+38%
Brand preference vs peers
9.2% vs 6.7% avg
Brand vs Generic
Brand: 802 claims · $1.3M
Generic: 7,916 claims · $265K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Valbenazine Tosylate | 27 | $210K |
| Brexpiprazole | 114 | $174K |
| Cariprazine Hcl | 119 | $173K |
| Lurasidone Hcl | 92 | $144K |
| Paliperidone Palmitate | 28 | $100K |
| Aripiprazole Lauroxil | 30 | $92K |
| Vortioxetine Hydrobromide | 116 | $64K |
| Lurasidone Hcl | 65 | $35K |
| Aripiprazole | 12 | $33K |
| Lumateperone Tosylate | 18 | $30K |
| Asenapine Maleate | 11 | $22K |
| Aripiprazole | 335 | $22K |
| Olanzapine/Samidorphan Malate | 12 | $19K |
| Asenapine Maleate | 56 | $18K |
| Suvorexant | 34 | $15K |
Prescribing Profile
56
Unique Drugs
12.0
Anomaly Score
Patient Profile
61
Avg Age
65%
Female
2.03
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data